Javascript is disabled

Javascript seems to be disabled. This will break some core site features. Please enable javascript or revisit this site from another device.

 

 

  1. Private market uptake of varicella vaccination and related sociodemographic differences: A Danish nationwide observational study

             Falch-Jørgensen Anne Cathrine

  1. The Impact of Moderate and Severe Varicella Infections on Danish Children Under 18 Years Old

              Egeskov-Cavling Amanda Marie

  1. Estimates of the health and economic burden of pneumococcal diseases attributable to v116, pcv24 and pcv20 serotypes among adults in finland

             Tolvanen Tiina

  1. A phase 1b/2a single dose ascending dose study to evaluate the safety, tolerability, and pharmakokinetics of an RSV-neutralizing antibody, clesrovimab, in pre-term and full-term infants

             Brevik-Andersen Merethe

  1. A phase 3 clinical study to evaluate the safety, tolerability, and immunogenicity of v116 in pneumococcal vaccine-experienced adults 50 years of age or older (stride-6)

             Tajik Athar Ali

  1. Immunogenicity of v116 (21-valent pcv) in pneumococcal-naïve adults 50–64, 65–74, and ≥75years of age: subgroup analysis of a randomized phase 3 trial (stride-3)

             Elbrond Bodil

  1. A Phase 3, randomised trial investigating the safety, tolerability and immunogenicity of V116, an adult-specific pneumococcal conjugate vaccine, compared with PPSV23, in adults ≥50 years of age (STRIDE-10)

             Elbrond Bodil

  1. Nordic Covid-19 vaccine policy, similarities and disparities in handling two incidents of potentially severe safety signals

             Rubin Johanna

  1. Influenza vaccination in Norway 2014/15-2022/23 – coverage by age and educational attainment in risk groups and health care workers

             Klüwer Birgitte

  1. The pertussis epidemic in Denmark, 2023

               Dalby Tine

  1. Avian influenza vaccine induced immune responses – study design and methods of a clinical vaccine trial in Finland

             Ekström Nina

  1. Immunogenicity and safety of Pneumococcal Vaccines Co-administered with Common Travel Vaccines in Adults: A Systematic Review

              Rezahosseini Omid

  1. Special populations addressed in vaccines approved via the European Medicines Agency

             Gräf Débora